Vitiligo in a Patient Receiving Adalimumab for Idiopathic Uveitis
In recent years, adalimumab has been increasingly used in the chronic treatment of non-infectious uveitis. This case report aimed to describe a drug-induced adverse event in a 34-year-old man who presented with blurred vision and floaters in the right eye and was being treated for intermediate uveit...
| Published in: | Türk Oftalmoloji Dergisi |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Turkish Ophthalmology Society
2024-04-01
|
| Subjects: | |
| Online Access: |
http://www.oftalmoloji.org/archives/archive-detail/article-preview/vitiligo-in-a-patient-receiving-adalimumab-for-dio/64992
|